Unlock instant, AI-driven research and patent intelligence for your innovation.

Human single-chain antibody 4c-scfv against enzymatic activity of botulinum toxin type b and its application

A 4c-scfv, botulinum toxin technology, applied in the direction of antibodies, applications, anti-toxins, etc., can solve problems such as immune response or infectious diseases

Active Publication Date: 2019-06-04
MILITARY VETERINARY RES INST PLA MILITARY MEDICAL ACAD OF SCI
View PDF4 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0030] The purpose of the present invention is to solve the problem that heterologous serum antibody causes immune response or infectious disease in the treatment of type B botulinum toxin, and provides a kind of Fully human single-chain antibody 4C-scFv, human single-chain antibody 4C-scFv against type B botulinum toxin enzymatic activity

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Human single-chain antibody 4c-scfv against enzymatic activity of botulinum toxin type b and its application
  • Human single-chain antibody 4c-scfv against enzymatic activity of botulinum toxin type b and its application
  • Human single-chain antibody 4c-scfv against enzymatic activity of botulinum toxin type b and its application

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0044] Example 1: Synthesis of Botulinum Toxin Type B Light Chain Gene

[0045] According to the complete gene sequence of botulinum toxin type B reported by Genbank, the light chain gene was designed and synthesized, and EcoR was inserted at the same time and Nde Restriction site, clone the gene fragment into pMD-19T vector, and transform it into JM109.

Embodiment 2

[0046] Embodiment 2: Botulinum toxin type B light chain gene is connected with PET-28a carrier

[0047]EcoR and Nde Double-digested plasmid pMD-19T-Bont-B, the digested product was analyzed by agarose gel electrophoresis, the results are shown in figure 2 As shown, the target gene BontB with a size of about 1335 can be seen, which is consistent with the expected size;

[0048] EcoR and Nde The large fragment of the double-digested vector PET-28a and the small fragment of the target gene BontB were recovered and ligated with T4 DNA ligase to obtain the recombinant plasmid PET-28a-BontB, which was transformed into Escherichia coli JM109 competent cells and carried out on agarose plates containing kan resistance. initial screening. Pick a single colony and culture it in LB liquid medium; extract the plasmid with a plasmid recovery kit.

[0049] Insertion of EcoR by synthesis and Nde Botulinum toxin type B light chain gene sequence at the restriction site, and prime...

Embodiment 3

[0054] Embodiment 3: SDS-PAGE result analysis of recombinant protein PET-28a-BontB expression product

[0055] The recombinant plasmid PET-28a-BontB was transformed into the expression strain Escherichia coli BL21 (DE3), and the expression was induced by IPTG. The results of SDS-PAGE showed that the recombinant protein PET-28a-BontB had an obvious expression band at about 50KD, and the size was the same as the theoretical value. match; see Figure 5 ;

[0056] SDS-PAGE electrophoresis was performed on the supernatant and the precipitate of the lysate of the recombinant protein expressing bacteria at the same time. The ratio of the supernatant to the precipitate was 1:10. The results showed that most of the target protein was in the supernatant, and there was also a small amount of the target protein in the corresponding position It is believed that through the optimization of induction conditions, it can be expressed in a soluble form under a suitable induction environment, s...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
molecular weightaaaaaaaaaa
Login to View More

Abstract

The invention provides a human-derived single-chain antibody 4C-scFv resisting botulinum toxin type B enzyme activity. According to the invention, with an artificially synthesized recombinant protein BontB and a primer GFP-HIS6-SNAP25(62)-VAMP(57)-C used for screening the human-derived single-chain antibody 4C-scFv resisting botulinum toxin type B enzyme activity, the human-derived single-chain antibody 4C-scFv is screened from a human-derived anti-botulinum-toxin-type-B-enzyme antibody library. An affinity constant of the antibody is (4.38+ / -0.445)*10<5>L / mol. According to the invention, a basis is provided for producing special-effect treatment drugs resisting botulinum toxin type B, and for rapid detection of botulinum toxin type B.

Description

technical field [0001] The invention belongs to the field of biological technology, and in particular relates to a human single-chain antibody 4C-scFv against enzymatic activity of type B botulinum toxin, and its application, in the production and treatment of type B botulinum toxin enzymatic poisoning drugs, and detection of type B botulinum toxin Enzyme applications. Background technique [0002] Botulinum toxin can cause botulism in humans and animals. Its infectious dose is extremely low. From primate experiments, the lowest lethal dose (LD50) is 1ng / kg. Therefore, it has been approved by the US Centers for Disease Control and Prevention. Designated as a biological weapon that poses a threat to humans similar to anthrax. The causes of botulism can be roughly divided into four types, 1. Adult botulism. Second, infant infectious botulism. Three, wound infection botulism. [0003] Botulinum toxin is formed by Clostridium botulinum in the natural state or in the culture ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): C07K16/12C12N15/13A61K39/40A61P39/02G01N33/68
Inventor 张国利田园刘雪于佳李玉洁刘雨玲岳玉环吴广谋李爽史飞赵鑫徐艳玲张培培
Owner MILITARY VETERINARY RES INST PLA MILITARY MEDICAL ACAD OF SCI